BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1942540)

  • 21. Detection of carriers in Glanzmann's thrombasthenia.
    Zonneveld GT; van Leeuwen EF; Sturk A; ten Cate JW
    Thromb Haemost; 1983 Jun; 49(3):182-6. PubMed ID: 6224309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation for Glanzmann's thrombasthenia.
    Johnson A; Goodall AH; Downie CJ; Vellodi A; Michael DP
    Bone Marrow Transplant; 1994 Jul; 14(1):147-50. PubMed ID: 7951102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum.
    Ali N; Moiz B; Shaikh U; Adil S; Rizvi B; Rahman Y
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):91-4. PubMed ID: 18454893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
    Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
    Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of glycoprotein deficiencies in Glanzmann's thrombasthenia.
    Meyer M; Herrmann FH
    Thromb Haemost; 1985 Oct; 54(3):626-9. PubMed ID: 2935964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and function of transfused platelets. Studies in two patients with congenital deficiencies of platelet membrane glycoproteins.
    Cesar JM; Vecino AM
    Platelets; 2009 May; 20(3):158-62. PubMed ID: 19437332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostasis in Glanzmann's thrombasthenia (GT): GT platelets interfere with the aggregation of normal platelets.
    Jennings LK; Wang WC; Jackson CW; Fox CF; Bell A
    Am J Pediatr Hematol Oncol; 1991; 13(1):84-90. PubMed ID: 2029084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous Cys542-->Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann's thrombasthenia.
    Ruan J; Schmugge M; Clemetson KJ; Cazes E; Combrie R; Bourre F; Nurden AT
    Br J Haematol; 1999 May; 105(2):523-31. PubMed ID: 10233432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of RFLP using TspRI for carrier detection in Glanzmann's thrombasthenia: a report on two families.
    Kannan M; Yadav BK; Ahmad F; Saxena R
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e158-62. PubMed ID: 19170775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glanzmann's thrombasthenia: first case descriptions in sub-Saharan Africa].
    Dokekias AE; Galiba FO; Koko I
    Tunis Med; 2008 Aug; 86(8):761-3. PubMed ID: 19472764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Membrane glycoproteins of human platelets: structures, functions, and abnormalities in Glanzmann's thrombasthenia and Bernard-Soulier syndrome].
    Ando Y; Fusegawa H; Kawada T; Tanaka Y; Watanabe K; Kobayashi N
    Rinsho Byori; 1989 Dec; 37(12):1344-52. PubMed ID: 2614964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia.
    Kunicki TJ; Aster RH
    J Clin Invest; 1978 May; 61(5):1225-31. PubMed ID: 566280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals.
    Nomura S; Komiyama Y; Murakami T; Funatsu A; Kokawa T; Sugo T; Matsuda M; Yasunaga K
    Int J Hematol; 1993 Oct; 58(3):203-12. PubMed ID: 8148498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet glycoprotein Ib in a patient with chronic renal failure and Glanzmann's thrombasthenia.
    Nomura S; Kawamura H; Shouzu A; Kokawa T; Yasunaga K
    Br J Haematol; 1992 May; 81(1):131. PubMed ID: 1482473
    [No Abstract]   [Full Text] [Related]  

  • 37. Flow cytometric analysis of platelet surface antigens.
    Marti GE; Magruder L; Schuette WE; Gralnick HR
    Cytometry; 1988 Sep; 9(5):448-55. PubMed ID: 3180946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry.
    Jennings LK; Ashmun RA; Wang WC; Dockter ME
    Blood; 1986 Jul; 68(1):173-9. PubMed ID: 3719095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PMA induces platelet activation of specific antigens (CD62/CD63) in GpIIb-IIIa deficient platelets from Glanzmann's thrombasthenia.
    Baudouin-Brignole F; Bayle J; Goguel A; Philip PJ
    Platelets; 1997; 8(6):391-5. PubMed ID: 16793673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of Glanzmann's thrombasthenia and Bernard-Soulier syndrome using flow cytometry].
    Nomura S; Nagata H; Kitada T; Sone N; Oda K; Kokawa T; Yasunaga K; Nakajima T; Endo K
    Rinsho Ketsueki; 1987 Mar; 28(3):377-85. PubMed ID: 3613125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.